Obulytix

The world is facing an unprecedented antimicrobial resistance crisis with regular antibiotics losing their efficacy against antibiotic-resistant bacteria. Obulytix is a biotechnology company focused on the discovery and development of a groundbreaking class of enzyme-based antibiotics to combat the most severe antibiotic-resistant bacteria.

Armed with our expertise and great commitment, we're here to make a real difference. Our mission is to provide concrete solutions to this pressing global challenge and to save the lives of countless patients battling life-threatening conditions.